Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China

BACKGROUND: Autologous stem cell transplantation (ASCT) has been recommended as a standard approach for young multiple myeloma (MM) patients for decades, even in the era of novel agents. Gain of chromosome 1q21 is a common cytogenetic abnormality in MM, while its clinical prognostic value is still c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, Jian, Yuan, Du, Juan, Li, Xiaozhe, Zhou, Huixing, Zhang, Zhiyao, Yang, Guangzhong, Wang, Guorong, Tian, Ying, Li, Yanchen, Wu, Yin, Fu, Weijun, Li, Juan, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643680/
https://www.ncbi.nlm.nih.gov/pubmed/32881351
http://dx.doi.org/10.1002/cam4.3254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643680/
https://www.ncbi.nlm.nih.gov/pubmed/32881351
http://dx.doi.org/10.1002/cam4.3254

Ejemplares similares